178 related articles for article (PubMed ID: 37046029)
21. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
22. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
O'Keefe D; Aitken C; Scott N; Dietze P
Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
[TBL] [Abstract][Full Text] [Related]
23. Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs.
Adams M; An Q; Broz D; Burnett J; Wejnert C; Paz-Bailey G;
AIDS Behav; 2019 Dec; 23(12):3306-3314. PubMed ID: 31512066
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and correlates of HIV infection among men who inject drugs in a remote area of Vietnam.
Nghiem VT; Bui TC; Nadol PP; Phan SH; Kieu BT; Kling R; Hammett TM
Harm Reduct J; 2018 Feb; 15(1):8. PubMed ID: 29444685
[TBL] [Abstract][Full Text] [Related]
25. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.
Bluthenthal RN; Anderson R; Flynn NM; Kral AH
Drug Alcohol Depend; 2007 Jul; 89(2-3):214-22. PubMed ID: 17280802
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with HIV testing among people who inject drugs: a meta-analysis.
Bayani A; Ghiasvand H; Rezaei O; Fattah Moghaddam L; Noroozi A; Ahounbar E; Higgs P; Armoon B
J Addict Dis; 2020; 38(3):361-374. PubMed ID: 32552504
[TBL] [Abstract][Full Text] [Related]
27. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ
Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009
[TBL] [Abstract][Full Text] [Related]
28. Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden.
Kågström E; Lannergård A; El Khosht J; Lörelius P; Månflod J; Strömdahl S
Harm Reduct J; 2023 Jun; 20(1):77. PubMed ID: 37328868
[TBL] [Abstract][Full Text] [Related]
29. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
[TBL] [Abstract][Full Text] [Related]
30. Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009.
Topp L; Day CA; Iversen J; Wand H; Maher L;
AIDS; 2011 Mar; 25(6):835-42. PubMed ID: 21192232
[TBL] [Abstract][Full Text] [Related]
31. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
[TBL] [Abstract][Full Text] [Related]
32. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling.
Vickerman P; Platt L; Jolley E; Rhodes T; Kazatchkine MD; Latypov A
Int J Drug Policy; 2014 Nov; 25(6):1163-73. PubMed ID: 25449056
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
34. Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015.
Whiteman A; Burnett J; Handanagic S; Wejnert C; Broz D;
Int J Drug Policy; 2020 Nov; 85():102923. PubMed ID: 32920424
[TBL] [Abstract][Full Text] [Related]
35. Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts.
Huang YF; Yang JY; Nelson KE; Kuo HS; Lew-Ting CY; Yang CH; Chen CH; Chang FY; Liu HR
PLoS Med; 2014 Apr; 11(4):e1001625. PubMed ID: 24714449
[TBL] [Abstract][Full Text] [Related]
36. A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.
Marotta PL; McCullagh CA
Int J Drug Policy; 2016 Jun; 32():3-10. PubMed ID: 27212656
[TBL] [Abstract][Full Text] [Related]
37. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
[TBL] [Abstract][Full Text] [Related]
38. Estimating the cost-effectiveness of needle-syringe programs in Australia.
Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
[TBL] [Abstract][Full Text] [Related]
39. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.
Luo W; Wu Z; Poundstone K; McGoogan JM; Dong W; Pang L; Rou K; Wang C; Cao X
Addiction; 2015 Jan; 110 Suppl 1():61-7. PubMed ID: 25533865
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
